Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment
Se Ryeon Lee, Hojoon Choi, Byung Hyun Lee, Ka-Won Kang, Eun Sang Yu, Dae Sik Kim, Yong Park, Chul Won Choi, Byung Soo Kim, Hwa Jung Sung
Korean J Intern Med. 2019;34(6):1333-1346. Published online 2018 Oct 26 DOI: https://doi.org/10.3904/kjim.2018.144
Citations to this article as recorded by 
Review of Small Molecule Anticancer NF-κB Inhibitors
Sh. R. Kzyrgalin, R. S. Yamidanov, K. A. Nazmieva, Sh. Kh. Gantsev
Creative surgery and oncology.2023; 13(2): 143. CrossRef
Case 16: A 75-Year-Old Man With Macroglossia and Hypercalcemia
Jinyoung Kim, Nanyeong Kim, Youngwoo Jeon, Tong-Yoon Kim, Tae-Jung Kim, Hyuk-Sang Kwon, Chul Soo Park, Ki-Hyun Baek
Journal of Korean Medical Science.2023;[Epub] CrossRef
Real-Life Experience With First-Line Therapy Bortezomib Plus Melphalan and Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma Ineligible for High Dose Chemotherapy With Autologous Stem-Cell Transplantation
Gabriele Buda, Maria Livia Del Giudice, Elisabetta Antonioli, Francesco Ghio, Enrico Orciuolo, Riccardo Morganti, Francesca Martini, Michela Staderini, Sara Galimberti, Mario Petrini
Frontiers in Medicine.2021;[Epub] CrossRef